Characteristic | Primary Cohort (n = 283) | Validation Cohort (n = 125) | ||
---|---|---|---|---|
No. of Patients | % | No. of Patients | % | |
Age | ||||
≤ 45 | 136 | 48.1 | 62 | 49.6 |
> 45 | 147 | 51.9 | 63 | 50.4 |
Histological grade | ||||
G1 | 22 | 7.8 | 12 | 9.2 |
G2 | 147 | 51.9 | 67 | 53.6 |
G3 | 114 | 40.3 | 46 | 36.8 |
Tumor invasion depth | ||||
≤ 1/2 | 219 | 77.4 | 72 | 57.6 |
> 1/2 | 64 | 22.6 | 53 | 42.4 |
Tumor size | ||||
≤ 4 | 155 | 54.8 | 78 | 60.0 |
> 4 | 128 | 45.2 | 52 | 40.0 |
Lymphovascular invasion | ||||
No | 233 | 82.3 | 87 | 69.6 |
Yes | 50 | 17.7 | 38 | 30.4 |
FIGO stage | ||||
IA | 65 | 23.0 | 31 | 24.8 |
IB | 166 | 58.7 | 59 | 47.2 |
IIA | 52 | 18.4 | 35 | 28.0 |
Radiotherapy | ||||
No | 241 | 85.2 | 90 | 72.0 |
Yes | 42 | 14.8 | 35 | 28.0 |